Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 242 entries
View as:

Rotigotine Restless Legs Syndrome Dose Finding Trial

Phase: N/A Priority: Normal
NCT ID: NCT00243217 Org: User:
Start: 04/30/03 End: 02/29/04 Due: 02/28/05

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01394224 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01300819 Org: User:
Start: 02/28/11 End: 11/30/12 Due: 11/30/13

Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

Phase: N/A Priority: Normal
NCT ID: NCT00843778 Org: User:
Start: 01/31/09 End: 12/31/12 Due: 12/31/13

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00615615 Org: User:
Start: 09/30/99 End: 03/31/03 Due: 03/31/04

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00242008 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01242488 Org: User:
Start: 11/30/10 End: 06/30/12 Due: 06/30/13

CDP323 Biomarker Study

Phase: N/A Priority: Normal
NCT ID: NCT00726648 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT01276119 Org: User:
Start: 09/30/08 End: 10/31/09 Due: 10/31/10

A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01292265 Org: User:
Start: 02/28/11 End: 01/31/12 Due: 01/31/13

Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01534403 Org: User:
Start: 01/31/12 End: 02/28/15 Due: 02/28/16

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00631150 Org: User:
Start: 03/31/03 End: 07/31/04 Due: 07/31/05

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01618877 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00630630 Org: User:
Start: 11/30/02 End: 11/30/03 Due: 11/30/04

Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00266409 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01450111 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

Phase: N/A Priority: Normal
NCT ID: NCT00422422 Org: User:
Start: 07/31/11 End: 03/31/13 Due: 03/31/14

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

Phase: N/A Priority: Normal
NCT ID: NCT00593606 Org: User:
Start: 07/31/07 End: 12/31/07 Due: 12/31/08

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Phase: N/A Priority: Normal
NCT ID: NCT00619801 Org: User:
Start: 03/31/08 End: 07/31/08 Due: 07/31/09

A Follow-On Trial to Assess the Long Term Safety and Efficacy of SPM 927 in Painful Distal Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00235443 Org: User:
Start: 09/30/04 End: 07/31/08 Due: 07/31/09

Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00401830 Org: User:
Start: 10/31/06 End: 02/29/08 Due: 02/28/09

An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00237458 Org: User:
Start: 05/31/01 End: 03/31/11 Due: 03/31/12

National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)

Phase: N/A Priority: Normal
NCT ID: NCT01095393 Org: User:
Start: 09/01/09 End: 12/31/19 Due: 12/31/20

Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00522522 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00464269 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10